Holdings report, as a money manager
Open the filing on sec.gov
Pfizer Inc. (PFE)
NYSE: PFE · Pharmaceutical Preparations · New York, NY · filing with the SEC since 1994
Grade5.9
◀ Past 6.7● Present 6.7▶ Future 4.1
The companyfiscal 2025, as filed
Revenue$62.58B-1.6%
Net income$7.77B-3.2%
Earnings per share$1.36-3.5%
Operating cash flow$11.70B-8.2%
Cash$1.14B+9.5%
Debt$61.64B+7.4%
Shareholders’ equity$86.78B-1.9%
Shares, diluted5.71B+0.2%
Return on equity9.0%
The recordfrom its filings
Filings in 2026117
Newest filingNov 12 · 13F-HR
Annual reportFeb 26, 2026
Quarterly reportNov 3, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$100,000
Insider buys, 12 months$3.0M
Patents granted11,714
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $63.63BNet income $4.03BCash from operations $14.17Bthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Large holder notice
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.